维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="WEDAM SB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Antiangogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
2	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA	2006	J Clin Oncol2006，24，5：	1
3	Neoadjuvant docetaxelfollowed by adjuvant doxorubicin and cyclophosphamide inpatients with stage III breast cancer显示文摘	Gradishar WJ Wedam SB Jahanzeb M	2005	Ann Oncol2005，16，8：	1
4	Phase Ⅱ clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer显示文摘	Wedam SB Lee JJ	2005	J Clin Oncol2005，23，12：	1
5	Neoadjuvant do- cetaxel fallowed by adjuvant doxorubicin and cyclophosphamide in patients with stage In breast cancer显示文摘	Gradishar WJ Wedam SB Jahanzeb M	2005	Ann Oncol2005，16，8：	1
6	Antiangiogenic and antitumoreffects of bevacizumab in patients with inflammatory and locally ad-vanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
7	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
8	Antiangiogenic andantitumor effects of bevacizumab in patients with inflammatoryand locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	/ Clin Oncol2006，24，5：	1
9	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
10	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
11	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA	2006	Clin Oncol2006，24，5：	1
12	Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer显示文摘	Gradishar WJ Wedam SB Jahanzeb M	2005	Ann Oncol2005，16，8：	1
13	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally ad- vanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Onco12006，24，5：	1
14	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer 显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
15	Antiangiogenic and antitumoreffects of bevacizumab in patient s with in flammatoryand locally advanced breast cancer显示文摘	Wedam SB Low JA	2006	Clin Oncol2006，24，5：	1
16	Antiangiogenic and antitumor effects of bevacizurnab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，：	1
17	Phase Ⅱ clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer显示文摘	LOW JA WEDAM SB LEE JJ	2005	J Clin Oncol2005，23，12：	1
18	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1
19	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA	2006	J Clin Oncol2006，24，5：	1
20	Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer显示文摘	Wedam SB Low JA Yang SX	2006	J Clin Oncol2006，24，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示